Immune to Cancer: The CRI Blog
-
How COVID-19 is Impacting Care for Lung Cancer Patients
CRI spoke with Dr. Joshua Sabari about how clinical care for lung cancer patients has been impacted…
-
Analytical Strategies in Immunology for Cancer and COVID-19 with Dr. Katie Campbell
Dr. Campbell’s work as a CRI fellow at UCLA is improving our understanding of both cancer and…
-
Cancer, COVID-19, and the Immune Genome with Dr. Brian Brown
CRI Technology Impact Award recipient Dr. Brian Brown has been developing a technology to help us better…
-
Melanoma Monday: 2020 Immunotherapy Research Update
Bringing immunotherapy earlier into treatment, extraordinary patient journeys, and how we’re working toward a future immune to…
-
Melanoma and Immunotherapy: Tara’s Journey to Become a Cancer Patient Advocate
Melanoma veteran Tara Ryan shares her experience with taking control of her health, resilience in the face…
-
AACR20 Day 2 Highlights: COVID-19, Adoptive Cell Therapy, and Checkpoint Immunotherapy Insights
The second day of AACR’s annual meeting heard from experts at cancer centers in COVID-19 hotspots around…
-
AACR20 Day 1 Highlights: Breast Cancer, Lung Cancer, and the Microbiome
The first day of the 2020 AACR Annual Meeting shared latest data from immunotherapy clinical trials in…
-
Esophageal Cancer Awareness Month: 2020 Immunotherapy Research Update
Promising new research, a variety of immunotherapy treatment combinations, and how we’re working toward a future immune…
-
How Immunotherapy for Esophageal Cancer is Making an Impact
Dr. Deirdre Cohen discusses recent advances in immunotherapy for esophageal cancer, including biomarkers, checkpoint inhibitors, cell-based therapies,…
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.